FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/03/004478 [Registered on: 18/03/2014] Trial Registered Retrospectively
Last Modified On: 30/04/2015
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Homoeopathy in hypertension 
Scientific Title of Study   Individualized homoeopathy versus placebo in essential hypertension: a double-blind randomized controlled trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
1343/MBHMCH/CH/H/01/11(A)  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Subhranil Saha 
Designation  Senior Research Fellow 
Affiliation  Central Council for Research in Homeopathy, Government of India 
Address  Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Darjiling
WEST BENGAL
734006
India 
Phone  913532596065  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Subhranil Saha 
Designation  Senior Research Fellow 
Affiliation  Central Council for Research in Homeopathy, Government of India 
Address  Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Darjiling
WEST BENGAL
734006
India 
Phone  913532596065  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Subhranil Saha 
Designation  Senior Research Fellow 
Affiliation  Central Council for Research in Homeopathy, Government of India 
Address  Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Clinical Research Unit (Homeopathy), Gokhel Road, Arabindapally
Darjiling
WEST BENGAL
734006
India 
Phone  913532596065  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Source of Monetary or Material Support  
Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal 
 
Primary Sponsor  
Name  Mahesh Bhattacharyya Homoeopathic Medical College Hospital Government of West Bengal 
Address  Drainage Canal Road, Doomurjala, Howrah 711104, West Bengal, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikhil Saha Principal inCharge  Hypertension OPD: Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, every Tuesday  Drainage Canal Road, Doomurjala, Howrah 711104
Haora
WEST BENGAL 
03326774449
03326774449
principalmbhmch@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of Mahesh Bhattacharyya Homoeopathic Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Essential hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized homoeopathic medicine  Single individualized homeopathic remedy orally in centesimal or 50 millesimal potencies as appropriate. Each dose in centesimal potency was single drop of medicine prepared in 88% dispensing alcohol in 5 ml distilled water. In 50 millesimal potency, a single medicated globule number 10 dissolved in 50 ml distilled water with addition of 2 drops of 88% dispensing alcohol, 10 doses marked, each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the bottle with hand on a firm surface in 45 ml water in a cup, to stir the mixture well, to take 5 ml of the mixture orally, and to discard rest of the liquid in cup. Repetition 24, 12 or 8 hourly or even oftener, depending upon the intensity of symptoms - total duration of such intervention 6 months. 
Comparator Agent  Placebo  Placebo indistinguishable from verum; identical in smell, taste and appearance; dispensed in similar manner to medicine;repetition 24, 12 or 8 hourly or even oftener - total duration of such intervention 6 months  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Age between 18 years and 65 years
2. Both sexes
3. Suffering from essential/primary hypertension for at least 6 months
4. History, examination, and routine investigations revealed no evidence of obvious secondary causes
5. Giving written informed consent 
 
ExclusionCriteria 
Details  1. Any continued anti-hypertensive therapy for at least 6 months
2. Malignant Hypertension with grave signs and symptoms as detected clinically
3. Patients suffering from isolated systolic hypertension
4. Patients with labile hypertension
5. Patients with secondary hypertension
6. Patients not strictly conforming to the criteria given by JNC-7; variation of ±10 mm Hg in SBP/DBP considerable
7. Presence of severe concomitant infectious or systemic disease(s)or organ failure, psychiatric illness, developmental or congenital anomalies, and/or complications of hypertension
8. Pregnancy, breast feeding and likelihood of pregnancy
9. History of abuse and/or dependence on drugs and/or alcohol 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pharmacy-controlled Randomization 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Change in systolic and diastolic blood pressure  6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Proportion of patients achieving reduction in the two groups  6 months 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   12/04/2011 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Hypertension is the most common cardiovascular disorder posing a major public health challenge to the population. Homoeopathy, although widely used in hypertension, is assumed to have nothing but placebo effects and its specific clinical effects are frequently ascribed as implausible. Aims were to evaluate whether individualized homoeopathy can produce any significant effect different from placebo in essential hypertension by comparing the lowering of blood pressure between groups. A prospective, double-blind, randomized, placebo-controlled, parallel arm clinical trial was conducted at the Outpatient Clinic of the Mahesh Bhattacharyya Homoeopathy Medical College and Hospital, West Bengal. Out of 233 hypertensives assessed for eligibility, 150 were enrolled and randomized (verum/homoeopathy 70, control/placebo 80). A total of 18 dropped out and 132 were regular (verum 64, control 68). The outcome measures were assessed after three months and six months. The intention-to-treat population was subjected to statistical analysis. Group differences were tested using the χ2 test and independent t test. Repeated measure (ANOVA) was performed to compare the data of two groups obtained longitudinally at baseline, three months and six months. The baseline data were not significantly different between the groups. After six months, mean Systolic Blood Pressure (SBP) reduction was 26.6 mm Hg (95% CI 21.5, 31.7) in the homoeopathy group and SBP increased by 3.6 mm Hg (95% CI 8.7, 1.5) in the placebo group. Similarly, the mean Diastolic Blood Pressure (SBP) in the homoeopathy group reduced by 11.8 mm Hg (95% CI 9.2, 14.4) and increased by 1.6 mm Hg (95% CI 3.6, 0.4) in the placebo group. Repeated measures ANOVA also showed significant difference (P=0.0001) between the groups. Natrum muriaticum, Calcarea carbonica, Sulphur, Thuja occidentalis, Nitric acid and Medorrhinum were frequently prescribed. Thus individualized homoeopathy produced a significantly different hypotensive effect than placebo. 
Close